Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma

Leukemia Research

Volumn 35, Issue 4, 2011, Pages 508-515

  Weiner, Alexandra S ^a   Beresina, Olga V ^b   Voronina, Elena N ^a   Voropaeva, Elena N ^b   Boyarskih, Uljana A ^a   Pospelova, Tatiana I ^b   Filipenko, Maxim L ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Folate metabolizing genes; Meta analysis; Non Hodgkin's lymphoma; Russian population; SNPs

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHYLENETETRAHYDROFOLATE SYNTHETASE; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLATE METABOLISM; GENE; GENE CONTROL; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFD GENE; MTHFR GENE; MTR GENE; MTRR GENE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; SHMT GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADOLESCENT; ADULT; AGED; ALLELES; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; GENOTYPE; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOMA, NON-HODGKIN; MALE; META-ANALYSIS AS TOPIC; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 79952362893     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.10.004     Document Type: Article

References (39)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics. CA Cancer J Clin 2009, 59:225-249.
2. Kovinev I., Loseva M., Pospelova T., Voropaeva E., Skvorcova N., Djachkova N. Non-Hodgkin's lymphoma, immunomorphology, who-classification of the lymphomas, epidemiology of the lymphomas. B{cyrillic}yu{cyrillic}l{cyrillic}l{cyrillic}ye{cyrillic}t{cyrillic}ye{cyrillic}n{cyrillic}{cyrillic small soft sign} CO PAMH 2006, 4:175-181.
3. Vose J.M., Chiu B.C., Cheson B.D., Dancey J., Wright J. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma. Hematology Am Soc Hematol Educ Program 2002, 241-262.
4. Fisher S.G., Fisher R.I. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004, 23:524-534.
5. Skibola C.F., Curry J.D., Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007, 92:960-969.
6. Choi S.W., Mason J.B. Folate and carcinogenesis: an integrated scheme. J Nutr 2000, 130:129-132.
7. Zijno A., Andreoli C., Leopardi P., Marcon F., Rossi S., Caiola S., et al. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 2003, 24:1097-1103.
8. Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry 2005, 70:651-669.
9. Rossi D., Capello D., Gloghini A., Franceschetti S., Paulli M., Bhatia K., et al. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 2004, 89:154-164.
10. Galm O., Herman J.G., Baylin S.B. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 2006, 20:1-13.
11. Christensen K.E., Rohlicek C.V., Andelfinger G.U., Michaud J., Bigras J.L., Richter A., et al. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects. Hum Mutat 2009, 30:212-220.
12. Koutros S., Zhang Y., Zhu Y., Mayne S.T., Zahm S.H., Holford T.R., et al. Nutrients contributing to one-carbon metabolism and risk of non-Hodgkin lymphoma subtypes. Am J Epidemiol 2008, 167:287-294.
13. Polesel J., Dal Maso L., La Vecchia C., Montella M., Spina M., Crispo A., et al. Dietary folate, alcohol consumption, and risk of non-Hodgkin lymphoma. Nutr Cancer 2007, 57:146-150.
14. Lim U., Schenk M., Kelemen L.E., Davis S., Cozen W., Hartge P., et al. Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998-2000. Am J Epidemiol 2005, 162:953-964.
15. Krajinovic M., Lemieux-Blanchard E., Chiasson S., Primeau M., Costea I., Moghrabi A. Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 2004, 4:66-72.
16. Wang L., Ke Q., Chen W., Wang J., Tan Y., Zhou Y., et al. Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Clin Cancer Res 2007, 13:2526-2532.
17. Paz M.F., Avila S., Fraga M.F., Pollan M., Gabriel C., Peinado M.A., et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002, 62(15):4519-4524.
18. Ulvik A., Avila S., Fraga M.F., Pollan M., Capella G., Peinado M.A., et al. Colorectal cancer and the methylenetetrahydrofolate reductase 677C→T and methionine synthase 2756A→G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004, 13:2175-2180.
19. Shekari M., Sobti R.C., Kordi Tamandani D.M., Suri V. Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 2008, 278:517-524.
20. Semmler A., Simon M., Moskau S., Linnebank M. The methionine synthase polymorphism c.2756A→G alters susceptibility to glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 2006, 15:2314-2316.
21. Kim H.N., Lee I.K., Kim Y.K., Tran H.T., Yang D.H., Lee J.J., et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008, 140:287-294.
22. Habib E.E., Aziz M., Kotb M. Genetic polymorphism of folate and methionine metabolizing enzymes and their susceptibility to malignant lymphoma. J Egypt Natl Canc Inst 2005, 17:184-192.
23. Siraj A.K., Ibrahim M., Al-Rasheed M., Bu R., Bavi P., Jehan Z., et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Ann Hematol 2007, 86:887-895.
24. Ismail S.I., Ababneh N.A., Khader Y., Abu-Khader A.A., Awidi A. Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma. Cancer Genet Cytogenet 2009, 195:120-124.
25. Skibola C.F., Forrest M.S., Coppede F., Agana L., Hubbard A., Smith M.T., et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004, 104:2155-2162.
26. Lim U., Wang S.S., Hartge P., Cozen W., Kelemen L.E., Chanock S., et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 2007, 109:3050-3059.
27. Timuragaoglu A., Dizlek S., Uysalgil N., Tosun O., Yamac K. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy. Ann Hematol 2006, 85:863-868.
28. Gonzalez Ordonez A.J., Fernandez Carreira J.M., Fernandez Alvarez C.R., Martin L., Sanchez Garcia J., Medina Rodriguez J.M., et al. Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma. Leuk Lymphoma 2000, 39:607-612.
29. Gemmati D., Ongaro A., Scapoli G.L., Della Porta M., Tognazzo S., Serino M.L., et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004, 13:787-794.
30. Lincz L.F., Scorgie F.E., Kerridge I., Potts R., Spencer A., Enno A. Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol 2003, 120:1051-1054.
31. Lightfoot T.J., Skibola C.F., Willett E.V., Skibola D.R., Allan J.M., Coppede F., et al. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 2005, 14:2999-3003.
32. Niclot S., Pruvot Q., Besson C., Savoy D., Macintyre E., Salles G., et al. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 2006, 108:278-285.
33. Berglund M., Enblad G., Turesson I., Edman V., Thunberg U. Folate-metabolizing genes in lymphoma patients from Sweden. Scand J Immunol 2009, 70:408-410.
34. Stanulla M., Seidemann K., Schnakenberg E., Book M., Mehles A., Welte K., et al. Methylenetetrahydrofolate reductase (MTHFR) 677C→T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population. Blood 2005, 105:906-907.
35. Seidemann K., Book M., Zimmermann M., Meyer U., Welte K., Stanulla M., et al. MTHFR 677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. Ann Hematol 2006, 85:291-300.
36. Gra O.A., Glotov A.S., Nikitin E.A., Glotov O.S., Kuznetsova V.E., Chudinovet A.V., et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol 2008, 83:279-287.
37. Linnebank M., Schmidt S., Kolsch H., Linnebank A., Heun R., Schmidt-Wolf I.G., et al. The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 2004, 90:1969-1971.
38. Lee K.M., Lan Q., Kricker A., Purdue M.P., Grulich A.E., Vajdic C.M., et al. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 2007, 122:525-533.
39. Hishida A., Matsuo K., Hamajima N., Ito H., Ogura M., Kagami Y., et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003, 88:159-166.